Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
2,59,594.00
2,27,934.00
2,08,859.00
1,65,615.00
1,54,900.00
1,10,384.00
1,05,104.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,59,594.00
2,27,934.00
2,08,859.00
1,65,615.00
1,54,900.00
1,10,384.00
1,05,104.00
Raw Material Cost
1,64,865.00
1,46,551.00
1,36,145.00
95,429.00
89,448.00
59,738.00
56,705.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,627.00
947.00
1,127.00
230.00
190.00
131.00
146.00
Selling and Distribution Expenses
55,274.00
50,493.00
51,934.00
40,160.00
34,881.00
25,909.00
24,200.00
Other Expenses
1,458.50
1,229.50
1,413.80
1,125.80
1,045.20
843.50
777.00
Total Expenditure (Excl Depreciation)
2,36,351.00
2,10,286.00
2,03,344.00
1,47,077.00
1,34,971.00
94,213.00
88,821.00
Operating Profit (PBDIT) excl Other Income
23243
17648
5515
18538
19929
16171
16283
Other Income
3,504.00
2,449.00
2,559.00
1,629.00
1,423.00
1,290.00
1,692.00
Operating Profit (PBDIT)
46,846.00
37,985.00
27,483.00
31,121.00
31,777.00
25,726.00
26,315.00
Interest
1,627.00
947.00
1,127.00
230.00
190.00
131.00
146.00
Exceptional Items
1,209.00
5,309.00
-2,340.00
2,308.00
-2,433.00
3,398.00
1,057.00
Gross Profit (PBDT)
94,729.00
81,383.00
72,714.00
70,186.00
65,452.00
50,646.00
48,399.00
Depreciation
20,099.00
17,888.00
19,409.00
10,954.00
10,425.00
8,285.00
8,340.00
Profit Before Tax
26,330.00
24,459.00
4,605.00
22,246.00
18,728.00
20,709.00
18,886.00
Tax
7,343.00
8,286.00
2,404.00
6,331.00
4,770.00
6,206.00
5,410.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18,986.00
16,173.00
2,201.00
15,914.00
13,958.00
14,503.00
13,475.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18,986.00
16,173.00
2,201.00
15,914.00
13,958.00
14,503.00
13,475.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18,986.00
16,173.00
2,201.00
15,914.00
13,958.00
14,503.00
13,475.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,71,625.00
1,55,893.00
1,36,894.00
1,32,169.00
1,16,599.00
1,04,649.00
91,771.00
Earnings per share (EPS)
385.7
328.58
43.72
316.19
271.93
272.61
253.31
Diluted Earnings per share
385.7
328.58
43.72
316.19
271.93
272.61
253.31
Operating Profit Margin (Excl OI)
8.95%
7.74%
2.64%
11.19%
12.87%
14.63%
15.49%
Gross Profit Margin
17.89%
18.58%
11.5%
20.05%
18.82%
26.27%
25.9%
PAT Margin
7.31%
7.1%
1.05%
9.61%
9.01%
13.14%
12.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 13.89% vs 9.13% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 17.39% vs 634.80% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.97% vs 42.58% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 71.81% vs -15.97% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Towa Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
2,59,594.00
94,035.00
1,65,559.00
176.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,59,594.00
94,035.00
1,65,559.00
176.06%
Raw Material Cost
1,64,865.00
35,773.00
1,29,092.00
360.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1,627.00
28.00
1,599.00
5,710.71%
Selling and Distribution Expenses
55,274.00
18,501.00
36,773.00
198.76%
Other Expenses
1,458.50
1,869.70
-411.20
-21.99%
Total Expenditure (Excl Depreciation)
2,36,351.00
72,999.00
1,63,352.00
223.77%
Operating Profit (PBDIT) excl Other Income
23,243.00
21,036.00
2,207.00
10.49%
Other Income
3,504.00
455.00
3,049.00
670.11%
Operating Profit (PBDIT)
46,846.00
24,045.00
22,801.00
94.83%
Interest
1,627.00
28.00
1,599.00
5,710.71%
Exceptional Items
1,209.00
-2,025.00
3,234.00
159.70%
Gross Profit (PBDT)
94,729.00
58,262.00
36,467.00
62.59%
Depreciation
20,099.00
2,554.00
17,545.00
686.96%
Profit Before Tax
26,330.00
19,435.00
6,895.00
35.48%
Tax
7,343.00
5,490.00
1,853.00
33.75%
Provisions and contingencies
0
0
0.00
Profit After Tax
18,986.00
13,945.00
5,041.00
36.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18,986.00
13,945.00
5,041.00
36.15%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18,986.00
13,945.00
5,041.00
36.15%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,71,625.00
1,52,634.00
18,991.00
12.44%
Earnings per share (EPS)
385.70
365.42
20.28
5.55%
Diluted Earnings per share
385.70
365.42
20.28
5.55%
Operating Profit Margin (Excl OI)
8.95%
22.37%
0.00
-13.42%
Gross Profit Margin
17.89%
23.38%
0.00
-5.49%
PAT Margin
7.31%
14.83%
0.00
-7.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 25,959.40 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 13.89% vs 9.13% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 1,898.60 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 17.39% vs 634.80% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,334.20 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 21.97% vs 42.58% in Mar 2024
Annual - Interest
Interest 162.70 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 71.81% vs -15.97% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.95%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
